Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended July 31, 2010
Business Overview: The Company manufactures laboratory furniture and equipment. It operates through Domestic and International segments. As of September 7, 2010, there were 2,573,100 shares of Common Stock outstanding.
Key Financial Metrics
| Metric (in thousands) | Q1 2011 (Ended July 31, 2010) | Q1 2010 (Ended July 31, 2009) |
|---|---|---|
| Net Sales | $24,858 | $26,249 |
| Gross Profit | $4,999 | $5,764 |
| Gross Margin | 20.1% | 22.0% |
| Operating Earnings | $1,098 | $1,798 |
| Net Earnings (Attributable to Kewaunee) | $657 | $1,071 |
| Diluted EPS | $0.25 | $0.42 |
| Cash from Operations | ($88) | $1,246 |
| Short-term Borrowings (Outstanding) | $7,496 | $4,872 (as of April 30, 2010) |
| Working Capital | $18,941 | $20,085 (as of April 30, 2010) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 5% year-over-year. Domestic operations fell 10% due to softness in the marketplace for small/mid-sized laboratory projects and shipment timing. Conversely, International operations increased 35% due to expanded opportunities.
- Margin Compression: Gross profit margin declined from 22.0% to 20.1%, primarily driven by lower sales prices in a competitive environment.
- Profitability Drop: Operating earnings decreased by approximately 39% ($1,098k vs $1,798k). Net earnings attributable to the Company dropped 39% to $657k.
- Cash Flow Shift: Operating cash flow turned negative ($88k used) compared to $1.246m provided in the prior year. This was driven by a $1.299m increase in accounts receivable, offsetting operating earnings.
- Debt Increase: Short-term borrowings increased by $2.624m during the quarter to fund operations and working capital needs.
Guidance, Outlook, and Risks
- Outlook: Management expects sales and earnings for the first half of fiscal year 2011 to be below prior year levels, followed by a stronger second half. This is based on order backlog delivery schedules, a partial global economic recovery, and new product introductions.
- Capital Projects: On August 2, 2010, the Company secured a $4 million seven-year term loan to fund the expansion of its Statesville, North Carolina manufacturing facilities. An interest rate swap was executed to fix the rate at 4.875%.
- Risks: Demand is dependent on laboratory construction projects and the Company's role as a subcontractor. Forward-looking statements are subject to economic, competitive, and technological risks.
- Liquidity: The Company maintains a $14 million revolving credit facility. Working capital decreased slightly to $18.9 million, with a current ratio of 1.9-to-1.0.
Investor Verification Checklist
- Receivables Growth: Verify the $1.299m increase in accounts receivable and its impact on future cash collections.
- Domestic Market Trends: Assess the sustainability of the 10% decline in domestic sales and the competitive pricing pressure affecting margins.
- Debt Covenants: Review the financial covenants associated with the new $4 million term loan and the existing revolving credit facility.
- International Expansion: Evaluate the 35% growth in international sales to determine if it can offset domestic weakness in future quarters.
- Capital Expenditures: Monitor the progress of the Statesville facility expansion funded by the new term loan.